paper-with-me

Papers

DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery

2025-05-20 · Kun Li, Zhennan Wu, Shoupeng Wang, Wenbin Hu

In the field of AI4Science, large-scale language models (LLMs) show great potential to parse complex scientific semantics, integrate cross-disciplinary knowledge, and assist critical task research. However, in the field of drug discovery, despite the optimization through professional data pre-training, context window expansion, and internet search, the existing LLMs are still facing challenges such as massive multi-modal and heterogeneous data processing, domain knowledge dynamic updating delay, and insufficient confidence in predicting the results of complex computational tasks. To address these challenges, we propose the DrugPilot, an LLM-based agent with parameterized reasoning for drug discovery. DrugPilot addresses key limitations of traditional end-to-end LLM prediction approaches through its parametric inference architecture. This agent system supports major phases of the drug discovery pipeline, facilitating automated planning and execution of multi-stage research tasks. To address the critical challenge of multi-modal drug data analysis (incorporating both public datasets and user-submitted data), we developed an interactive parameterized memory pool. This innovative component standardizes real-world drug data into parametric representations, simultaneously enabling efficient knowledge retrieval in multi-turn dialogue while mitigating the information loss inherent in text-based data transmission. Additionally, we created a drug instruct dataset across 8 essential drug discovery tasks for model fine-tuning and evaluation. Based on the Berkeley function calling evaluation framework, DrugPilot demonstrated the most advanced tool calling capabilities on our drug discovery tool instruction dataset, outperforming existing agents (e.g., ReAct, LoT). Specifically, it achieves task completion rates of 98.0%, 93.5%, and 64.0% on simple, multiple, and multi-turn tasks, respectively.

📄 PDF Abstract BibTeX arXiv:2505.13940

Code (1)

wzn99/drugpilot 공식 구현 pytorch

Tasks

Drug Discovery

Similar Papers 제목 키워드 기반

LIDDIA: Language-based Intelligent Drug Discovery Agent

2025-02-19 · Reza Averly, Frazier N. Baker, Xia Ning

Drug discovery is a long, expensive, and complex process, relying heavily on human medicinal chemists, who can spend years searching the vast space of potential therapies. Recent advances in artificial intelligence for c…

Drug DiscoveryNavigate

FROGENT: An End-to-End Full-process Drug Design Multi-Agent System

2025-08-14 · Qihua Pan, Dong Xu, Qianwei Yang, Jenna Xinyi Yao 외 arxiv

Drug discovery is a complex, multi-step pipeline that remains heavily dependent on manual, experience-driven operations; meanwhile, existing customized artificial intelligence tools are fragmented across web applications…

Drug Discovery

CP-Agent: Context-Aware Multimodal Reasoning for Cellular Morphological Profiling under Chemical Perturbations

2026-06-02 · Yuxin Zhang, Yiyao Li, Ping Shu Ho, Simon See 외 arxiv

Cell Painting combines multiplexed fluorescent staining, high-content imaging, and quantitative analysis to generate high-dimensional phenotypic readouts to support diverse downstream tasks such as mechanism-of-action (M…

Representation LearningMultimodal ReasoningDrug Discovery

DeepRoot: A KG-Coordinated Multi-Agent System for Therapeutic Reasoning over Historical Medical Texts

2026-06-14 · Zijian Carl Ma, Sean J. Wang, Sijbren Kramer, Li Erran Li arxiv

Historical medical archives and traditional medicines hold immense potential for drug discovery and remain a primary source for current drug development. However, pre-ontological prose and idiosyncratic taxonomies preven…

Drug Discovery

DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration

2024-11-24 · Sizhe Liu, Yizhou Lu, Siyu Chen, Xiyang Hu 외

Recent advancements in Large Language Models (LLMs) have opened new avenues for accelerating drug discovery processes. Despite their potential, several critical challenges remain unsolved, particularly in translating the…

Drug Discovery